These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin. Prignano F; Arnaboldi F; Cornaghi L; Landoni F; Tripo L; Preis FW; Donetti E Eur J Cell Biol; 2015 Feb; 94(2):71-7. PubMed ID: 25596626 [TBL] [Abstract][Full Text] [Related]
27. Sceptridium ternatum attenuates allergic contact dermatitis-like skin lesions by inhibiting T helper 2-type immune responses and inflammatory responses in a mouse model. Lim D; Kim MK; Jang YP; Kim J J Dermatol Sci; 2015 Sep; 79(3):288-97. PubMed ID: 26150208 [TBL] [Abstract][Full Text] [Related]
28. Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. Barland CO; Zettersten E; Brown BS; Ye J; Elias PM; Ghadially R J Invest Dermatol; 2004 Feb; 122(2):330-6. PubMed ID: 15009713 [TBL] [Abstract][Full Text] [Related]
29. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop. Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016 [TBL] [Abstract][Full Text] [Related]
30. Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation. Dearman RJ; Bhushan M; Cumberbatch M; Kimber I; Griffiths CE Exp Dermatol; 2004 Jul; 13(7):452-60. PubMed ID: 15217366 [TBL] [Abstract][Full Text] [Related]
31. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17. Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016 [TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice. Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438 [TBL] [Abstract][Full Text] [Related]
33. IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation. Uribe-Herranz M; Lian LH; Hooper KM; Milora KA; Jensen LE J Invest Dermatol; 2013 Jun; 133(6):1541-9. PubMed ID: 23407395 [TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373 [TBL] [Abstract][Full Text] [Related]
35. 5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice. Wang Y; Li Y; Wu Y; Jia L; Wang J; Xie B; Hui M; Du J Endocrinology; 2014 Jul; 155(7):2677-87. PubMed ID: 24877626 [TBL] [Abstract][Full Text] [Related]
36. IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway. Cho KA; Suh JW; Lee KH; Kang JL; Woo SY Int Immunol; 2012 Mar; 24(3):147-58. PubMed ID: 22207130 [TBL] [Abstract][Full Text] [Related]